SOURCE: Press Ventures

October 02, 2013 17:30 ET

Press Ventures Announces Completion of Industrial Design Study and 3D Engineering Schematics for Patented CLO-D Biosafety System

WARSAW, POLAND--(Marketwired - Oct 2, 2013) - Press Ventures Inc. (OTCQB: PVEN) ("Press Ventures" or the "Company"), through its wholly-owned Polish subsidiary Biosafety Systems, Inc. Sp z o.o., is pleased to announce that it has completed an industrial design study and generated engineering renderings for its patented ‎Cedar Leaf Oil Diffusion ("CLO-D") biosafety system.

"These new schematics will enable the Company to showcase its patented technology using the 3-D designs as a tool for parties interested in our solutions," stated Mr. Edward Denkiewicz, Press Ventures CEO. "Biosafety Systems' customers will be able to evaluate the mechanical workings of the systems and order units engineered specifically for their applications."

The CLO-D biosafety Systems schematics detail three unique product offerings for commercial, residential, and industrial applications. Mr. Denkiewicz concluded, "One of our main business drivers going forward is to enable the Company to automate the entire engineering procurement process to maximize our efficiencies, improve quality control, and better manage capital while achieving our full sales potential. The completion of these 3D schematics represents a significant milestone towards meeting that automation goal."

About Press Ventures

Press Ventures holds the worldwide rights to the patented Cedar Leaf Oil Diffusion ("CLO-D") technology for the use of natural products to kill bacteria, mold, and viruses in buildings. The patented CLO-D technology has been shown to be capable of killing many deadly bacterial and viral substances such as anthrax and H1N1 in buildings while they are still occupied. The CLO-D technology has been laboratory and field tested and the Company believes that use of the technology can provide a marked improvement in air quality and eliminate many of the most dangerous airborne bacteria, viruses, and pollutants. For additional information about CLO-D technology and Press Ventures, please visit www.biosafetysystemsinc.com

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, automation of the engineering procurement process, capability of the Company's technology and market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products or technologies and operating as a development stage company, our ability to retain important members of our management team and attract other qualified personnel, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, our ability to develop and commercialize products based on our technology platform, and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.

Contact Information